Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/20418
Title: A Fine Needle Recanalization Technique for Iliac Artery Occlusions in Endovascular Surgery
Authors: Cox, Daniel R A;Chiang, Nathaniel;Ramdwar, Noel;Chuen, Jason;Asadi, Hamed;Brooks, Duncan Mark
Affiliation: Department of Vascular Surgery, Austin Health, Heidelberg, Victoria, Australia
Department of Radiology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 1-Jan-2019
EDate: 2018-08-03
Citation: Annals of Vascular Surgery 2019; 54: 328-334
Abstract: Background: Endovascular intervention for chronic total occlusions (CTOs) in aortoiliac occlusive disease (AIOD) poses technical challenges. In this manuscript, our experience of fine needle recanalization for the treatment of iliac artery CTO is described. Method: A prospective database recorded treatment of 11 limbs in 11 patients since 2011 using this technique. The majority of these CTO were of the common iliac artery (n = 9). Results: Technical success rate was 91% (n = 10). One failed case was due to tortuous iliac anatomy. There was no restenosis of the treated segments at 8 weeks and no major complications, perforations, major limb loss, or periprocedural mortality. Conclusions: This technique is a safe and viable adjunct for difficult CTO in AIOD with suitable anatomy. It benefits from being a simple, low-profile, low-cost coaxial system and should be part of the armamentarium with other advanced endovascular techniques.
URI: http://ahro.austin.org.au/austinjspui/handle/1/20418
DOI: 10.1016/j.avsg.2018.05.041
ORCID: 0000-0002-5092-4370
0000-0002-0955-5446
0000-0003-2475-9727
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.avsg.2018.05.041
Type: Journal Article
Subjects: Arterial Occlusive Diseases
Endovascular Procedures
Iliac Artery
Type of Clinical Study or Trial: Case Series and Case Reports
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.